Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
株式のランク #12721
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
株価
$2.03
時価総額
$121.44M
変化(1日)
-0.93%
変化(1年)
-1.97%
FR
取引 Crossject Société Anonyme (ALCJ)

カテゴリー

Crossject Société Anonyme(ALCJ)のP/S比率
July 2026 時点のP/S比率 TTM: 71.80
Crossject Société Anonyme の最新の財務報告および株価によると、現在のP/S比率(TTM)は 71.80 です。2023 年末時点でのP/S比率は 1.26K でした。
Crossject Société Anonyme の P/S 比率の履歴(2010 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 71.80 194.15%
2024 24.41 -98.06%
2023 1.26K 911.76%
2022 124.63 55.54%
2021 80.13 434.26%
2020 15.00 -83.59%
2019 91.39 1,279.32%
2018 6.63 -47.30%
2017 12.57 -44.75%
2016 22.76 -47.42%
2015 43.28 8.99%
2014 39.71 -21.42%
2013 50.54 -54.97%
2012 112.23 83.88%
2011 61.03 -69.23%
2010 198.36 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差
13.31 -81.46%
US
2.65 -96.31%
FR
4.46 -93.79%
DE
9.16 -87.24%
JP
2.57 -96.43%
US